Second, epigenetic modifications can affect gene expression related to metabolic pathways (e.g., insulin signaling, adipogenesis, and lipid metabolism), increasing susceptibility to obesity and diabetes later in life [36–38]. The gene discussed is INS; the disease is obesity disorder.